Interaction with complement receptor 1 (CD35) leads to amelioration of sepsis-triggered mortality but aggravation of arthritis during Staphylococcus aureus infection

Scandinavian Journal of Immunology

Volumn 50, Issue 3, 1999, Pages 250-255

  Sakiniene, Egidija ^a   Heyman, B ^b   Tarkowski, A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Department of Rheumatology ^*

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY;

ANIMAL MODEL; ARTICLE; BACTERIAL ARTHRITIS; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE COURSE; HISTOPATHOLOGY; INFLAMMATION; MALE; MORTALITY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ARTHRITIS, INFECTIOUS; DISEASE MODELS, ANIMAL; FOLLOW-UP STUDIES; GRANULOCYTES; LEUKOCYTES; MALE; MICE; PHAGOCYTOSIS; RATS; RECEPTORS, COMPLEMENT 3B; SEPSIS; STAPHYLOCOCCAL INFECTIONS; T-LYMPHOCYTES;

EID: 0039238488     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00595.x     Document Type: Article

References (39)

1. 1 Sheagren J. Staphylococcus aureus. The persistent pathogen. N Engl J Med 1984;310:1368-73.
2. 2 Goldenberg DL. Bacterial arthritis. In: Kelly WO, Harris ED, Ruddy S, Sledge CB, eds. Textbook of Rheumatology. Philadelphia: W.B. Saunders, Co., 1989:1567-85.
3. 3 Bremell T. Holmdahl R, Tarkowski A. Protective role of sialophorin (CD43) expressing cells in experimental Staphylococcus aureus infection. Infect Immun 1994;62:4637-40.
4. 4 Verdrengh M, Tarkowski A. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 1997;65:2517-21.
5. 5 Abdelnour A, Bremell T, Holmdahl R, Tarkowski A. Role of T lymphocytes in experimental Staphylococcus aureus arthritis. Scand J Immunol 1994;39:403-8.
6. 6 Bremell T, Lange S, Holmdahl R, Ryden C, Hansson G, Tarkowski A. Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun 1994;62:2334-44.
7. 7 Zhao Y-X, Abdelnour A, Holmdahl R, Tarkowski A. Mice with the Xid B cell defect are less susceptible to developing Staphylococcus aureus induced arthritis. J Immunol 1995;155:2067-76.
8. 8 Zhao Y-X, Ljungdahl Å, Olsson T, Tarkowski A. In situ hybridization analysis of synovial and systemic cytokine mRNA expression in superantigen-triggered Staphylococcus aureus arthritis. Arthritis Rheum 1996;39:959-67.
9. 9 Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG. An interleukin 1 like factor stimulates bone resorption in vitro. Nature 1983;306:378-80.
10. 10 Sakiniene E, Bremell T, Tarkowski A. Inhibition of nitric oxide synthase aggravates Staphylococcus aureus septicemia and septic arthritis. Clin Exp Immunol 1997;110:370-7.
11. 11 Sakiniene E, Bremell T, Tarkowski A. Complement depletion aggravates Staphylococcus aureus septicemia and septic arthritis. Clin Exp Immunol 1999;115:95-102.
12. 12 Goodfellow RM, Williams AS, Levin JL, Williams BD, Morgan BP. Local therapy with soluble complement receptor 1 (sCRI) suppresses inflammation in rat mono-articular arthritis. Clin Exp Immunol 1997;110:45-52.
13. 13 Ross GD, Medof ME. Membrane complement receptors specific for bound fragments of C3. Adv Immunol 1985;37:217-67.
14. 14 Ahearn JM, Fearon DT. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol 1989;46: 183-219.
15. 15 Kinoshita T, Takeda J, Hong K, Kozono H, Sakai H, Inoue K. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J Immunol 1988;140: 3066-72.
16. 16 Bremell T, Lange S, Svensson Let al. Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum 1990;33:1739-44.
17. 17 Bremell T, Lange S, Yacoub A, Rydén C, Tarkowski A. Experimental Staphylococcus aureus arthritis in mice. Infect Immun 1991;59:2615-23.
18. 18 Abdelnour A, Arvidson S, Bremell T, Rydén C, Tarkowski A. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 1993;61:3879-85.
19. 19 Bremell T, Abdelnour A, Tarkowski A. Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun 1992;60:2976-85.
20. 20 Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965;2:235-54.
21. 21 Lue C, Tarkowski A, Mesteeky J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases both serum and secretory anti-pneumococcal antibodies. J Immunol 1988;140:3793-800.
22. 22 Russel MW, Brown TA, Radl J, Haaijman JJ, Mestecky J. Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies. J Immunol Methods 1986;87:87-93.
23. 23 Goldenberg DL, Cohen AS. Synovial membrane histopathology in the different diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease. Medicine 1978;57:239-52.
24. 24 Carlsten H, Holmdahl R, Tarkowski A, Nilsson L-A. Oestradiol-and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology 1989;68:209-14.
25. 25 Josefsson E, Tarkowski A, Carlsten H. Anti-inflammatory properties of estrogen. Cell Immunol 1992;142:67-78.
26. 26 Josefsson E, Carlsten H, Tarkowski A. Neutrophil mediated inflammatory response in murine lupus. Autoimmunity 1993;14.251-7.
27. 27 Herzog W-R, Ferreri NR, Ptak W, Askenase PW. The DTH-initiating Thy-1 + cell is double-negative (CD4 , CD8 ) and CD3 , and expresses IL-3 receptors, but no IL-2 receptors. J Immunol 1989;143:3125-33.
28. 28 Sadallah S, Lach E, Lutz HU, Schwarz S, Guerne P-A, Schifferli JA. CR1, CD35 in synovial fluid from patients with inflammatory joint diseases. Arthritis Rheum 1997;40:520-526.
29. 29 Herman JJ, Rosner IK, Davis, AE, Zeiger RS, Arnaout MA, Colten HR. Complement-dependent histaminase release from human granulocytes. J Clin Invest 1979;63:1195-202.
30. 30 Herman JJ, Colten HR. Specific modulation of complement-dependent human granulocyte function by imidazole acetic acid. J Allergy Clin Immunol 1980;66:274-80.
31. 31 Molina H, Kinoshita T, Webster CB, Holers VM. Analysis of C3b/ C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J Immunol 1994;153:789-95.
32. 32 Gordon DL, Rice J, Finlay-Jones JJ, McDonald PJ, Hostetter MK. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization. J Infect Dis 1988;157:697-704.
33. 33 Heyman B, Wiersma EJ, Kinoshita T. In vivo inhibition of antibody response by a complement receptor-specific monoclonal antibody. J Exp Med 1990;172:665-8.
34. 34 Thyphronitis G, Kinoshita T, Inoue K, Schweinle JE, Tsokos GC. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J Immunol 1991;147:224-30.
35. 35 Hebell T, Ahearn JM, Fearon DT. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 1991;254:102-5.
36. 36 Molina H, Holers VM, Li Bet al. Markedly impaired humoral immune responses in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 1996;93:3357-61.
37. 37 Ahearn JM, Fischer MB, Croix Det al. Disruption of the Cr2 locus results in a reduction in B-Ia cells and in an impaired B cell response to T-dependent antigen. Immunity 1996;4:251-62.
38. 38 Heyman B. The role of complement receptors in the regulation of the immune response. In: Erdei A, ed. New Aspects of Complement Structure and Function. Austin, Texas: R.G. Landes Co., 1994: 59-72.
39. 39 Gustavsson S, Kinoshita T, Heyman B. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J Immunol 1995;154:6524-8.